Literature DB >> 6418822

Use of the ELISA to detect and quantify histocompatibility antigens and their subunits.

A Ferreira, Y Revilla, A Bootello, P Gonzalez-Porqué.   

Abstract

A solid phase enzyme immunoassay (ELISA) has been developed for the detection and quantification of human histocompatibility antigens and their subunits. The assay involves the binding to a microELISA plate of a mouse monoclonal antibody reacting with a common antigenic determinant to all HLA (A, B, C) antigens. The standard conditions for the assay and the curves obtained for the quantification of total HLA, free beta 2m, and free heavy chain subunit (alpha) present in a biological sample are described and the sensitivity and potential uses of the method are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418822     DOI: 10.1016/0022-1759(83)90132-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin at delivery.

Authors:  A Ferreira; M C García Rodríguez; F Omeñaca; A Jiménez; L M Villar; P Gonzalez-Porqué; G Fontán
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

2.  Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay.

Authors:  I Doxiadis; U Westhoff; H Grosse-Wilde
Journal:  Blut       Date:  1989-11

Review 3.  Soluble HLA: patterns of expression in normal subjects, autoimmune diseases, and transplant recipients.

Authors:  Irena Adamashvili; Roger E Kelley; Thomas Pressly; John C McDonald
Journal:  Rheumatol Int       Date:  2005-06-29       Impact factor: 2.631

4.  Increased beta 2-microglobulin in CSF of multiple sclerosis.

Authors:  J C Alvarez-Cermeño; L M Villar; G Roy; A Ferreira; A Bootello; A Gimeno; P González-Porqué
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

5.  Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma.

Authors:  J A Brieva; L M Villar; G Leoro; J C Alvarez-Cermeño; E Roldán; P Gonzalez-Porqué
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.